Can we take the STING out of bone loss? Pathway presents potential treatment target for skeletal aging

Researchers have identified the STING signaling pathway as a potential target for treating age-related bone loss, a condition known as osteoporosis. This pathway plays a role in inflammation, which increases in bone marrow as we age, contributing to bone weakness and brittleness. The study suggests that targeting this pathway could help prevent or slow down bone loss in older adults.